C07K 16/2896
Against molecules with a "cd"-designation, not provided for elsewhere
Official title: {against molecules with a "CD"-designation, not provided for elsewhere}
C07K16/2896 (Against molecules with a "cd"-designation, not provided for elsewhere) appears on 2,467 US grants and 4,927 published applications in this corpus.
Search patents in C07K- Granted patents
- 2,467
- Published applications
- 4,927
- Assignees
- 1,513
- Inventors
- 7,841
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 4 | 0 |
| 1996 | 7 | 0 |
| 1997 | 12 | 0 |
| 1998 | 24 | 0 |
| 1999 | 25 | 0 |
| 2000 | 25 | 0 |
| 2001 | 24 | 5 |
| 2002 | 24 | 37 |
| 2003 | 15 | 82 |
| 2004 | 7 | 80 |
| 2005 | 16 | 92 |
| 2006 | 24 | 104 |
| 2007 | 32 | 91 |
| 2008 | 39 | 95 |
| 2009 | 40 | 115 |
| 2010 | 55 | 111 |
| 2011 | 47 | 124 |
| 2012 | 73 | 118 |
| 2013 | 94 | 164 |
| 2014 | 94 | 152 |
| 2015 | 96 | 192 |
| 2016 | 108 | 220 |
| 2017 | 140 | 200 |
| 2018 | 107 | 234 |
| 2019 | 147 | 290 |
| 2020 | 169 | 335 |
| 2021 | 166 | 317 |
| 2022 | 172 | 384 |
| 2023 | 157 | 405 |
| 2024 | 191 | 412 |
| 2025 | 194 | 315 |
| 2026 | 127 | 253 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Disruption of CD28-sialoside ligand complexes to enhance T cell activation6 Oct 2026US 12,752,014 B2The Scripps Research Institute
- Anti-ABCG2 antibodies and uses thereof6 Oct 2026US 12,753,241 B2William Robert Arathoon Living Trust Dated August 29, 2016
- Antibody conjugates and uses thereof6 Oct 2026US 12,753,242 B2GlycoNex Inc.
- CD73-binding protein and use thereof6 Oct 2026US 12,753,243 B2Huabo Biopharm (Shanghai) Co., Ltd.
- Monoclonal antibody used for diagnosis and early onset of prostate cancer6 Oct 2026US 12,753,244 B2Taipei Medical University
- Dual transporters and methods of use8 Oct 2026US 2026/0308269 A1Denali Therapeutics Inc.
- Immunotherapeutic proteins8 Oct 2026US 2026/0308271 A1Macfarlane Burnet Institute for Medical Research and Public Health Limited
- Slc4a1 (band 3) binding single domain antibodies for increased blood retention8 Oct 2026US 2026/0308272 A1
- Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof8 Oct 2026US 2026/0308274 A1Genentech, Inc.
- Methods and means for the production of ig-like molecules8 Oct 2026US 2026/0308655 A1Merus N.V.
Most cited
By later US patents
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997
- Humanized immunoglobulins and methods of making the same1,467US 6,180,370 B2Protein Design Labs, Inc. · 2001
- Polynucleotides encoding improved humanized immunoglobulins1,258US 5,693,761 AProtein Design Labs, Inc. · 1997